IRIS
DE LUCA, CATERINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.971
NA - Nord America 2.516
EU - Europa 2.192
SA - Sud America 342
AF - Africa 69
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 5
Totale 8.101
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.438
SG - Singapore 1.270
RU - Federazione Russa 1.012
VN - Vietnam 594
CN - Cina 536
IT - Italia 493
BR - Brasile 273
HK - Hong Kong 257
DE - Germania 162
FR - Francia 98
NL - Olanda 85
IN - India 77
GB - Regno Unito 74
FI - Finlandia 70
JP - Giappone 44
KR - Corea 38
CA - Canada 34
ES - Italia 32
AR - Argentina 30
MX - Messico 30
UA - Ucraina 29
BD - Bangladesh 28
PL - Polonia 26
IE - Irlanda 25
GR - Grecia 18
CI - Costa d'Avorio 17
ZA - Sudafrica 17
PH - Filippine 15
TH - Thailandia 15
IQ - Iraq 13
SE - Svezia 13
EC - Ecuador 12
ID - Indonesia 10
PK - Pakistan 10
LT - Lituania 9
TR - Turchia 9
TW - Taiwan 9
AT - Austria 8
CO - Colombia 7
JO - Giordania 7
EG - Egitto 6
MA - Marocco 6
MY - Malesia 6
PY - Paraguay 6
AL - Albania 5
CL - Cile 5
DZ - Algeria 5
SA - Arabia Saudita 5
TN - Tunisia 5
UZ - Uzbekistan 5
VE - Venezuela 5
AU - Australia 4
BE - Belgio 4
CZ - Repubblica Ceca 4
JM - Giamaica 4
KE - Kenya 4
RO - Romania 4
SY - Repubblica araba siriana 4
ET - Etiopia 3
KZ - Kazakistan 3
PE - Perù 3
AD - Andorra 2
BG - Bulgaria 2
BN - Brunei Darussalam 2
CH - Svizzera 2
EU - Europa 2
GE - Georgia 2
GT - Guatemala 2
LV - Lettonia 2
MN - Mongolia 2
NO - Norvegia 2
NP - Nepal 2
SK - Slovacchia (Repubblica Slovacca) 2
XK - ???statistics.table.value.countryCode.XK??? 2
A1 - Anonimo 1
AE - Emirati Arabi Uniti 1
BY - Bielorussia 1
CG - Congo 1
CR - Costa Rica 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GD - Grenada 1
GH - Ghana 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
HT - Haiti 1
HU - Ungheria 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
LU - Lussemburgo 1
MD - Moldavia 1
MT - Malta 1
NG - Nigeria 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
QA - Qatar 1
Totale 8.092
Salva come PNG Salva come JPEG
Città #
Singapore 618
San Jose 545
Chandler 257
Hong Kong 248
Moscow 239
Ashburn 215
Beijing 171
Ho Chi Minh City 170
Hanoi 120
Hefei 119
Naples 100
Los Angeles 76
Santa Clara 71
Munich 69
Lauterbourg 67
Millbury 61
Napoli 57
The Dalles 55
Amsterdam 47
Des Moines 40
Tokyo 37
Lawrence 35
Redondo Beach 35
São Paulo 33
Boston 31
Helsinki 30
Haiphong 27
New York 27
Orem 25
Seoul 25
Dallas 23
Buffalo 22
Council Bluffs 22
Da Nang 22
Kochi 21
Milan 21
Rome 21
Falkenstein 20
Frankfurt am Main 20
Warsaw 20
Wilmington 20
Princeton 19
Atlanta 17
Valencia 17
Biên Hòa 16
Nanjing 16
London 15
Montreal 15
Turku 15
Heraklion 14
Seattle 14
Chennai 13
Chicago 13
Rio de Janeiro 12
Casalnuovo di Napoli 11
Fairfield 11
Johannesburg 11
Nanchang 11
Brooklyn 10
Denver 10
Dublin 10
Stockholm 10
Can Tho 9
Mexico City 9
Nuremberg 9
Baghdad 8
Dong Ket 8
Guangzhou 8
Houston 8
Hải Dương 8
San Francisco 8
Ankara 7
Belo Horizonte 7
Lappeenranta 7
Amman 6
Bologna 6
Hebei 6
Mumbai 6
Phoenix 6
Poplar 6
Salerno 6
Buenos Aires 5
Cairo 5
Campinas 5
Düsseldorf 5
Manchester 5
Ottawa 5
Portici 5
Salvador 5
Santa Maria 5
Tashkent 5
Thái Nguyên 5
Toronto 5
Tân Tiến 5
Woodbridge 5
Berlin 4
Brasília 4
Guayaquil 4
Jiaxing 4
Kaohsiung 4
Totale 4.390
Salva come PNG Salva come JPEG
Nome #
Performance analysis of SiRe next-generation sequencing panel in diagnostic setting: focus on NSCLC routine samples 215
Cell free DNA analysis by SiRe® next generation sequencing panel in non small cell lung cancer patients: focus on basal setting. 183
Technical Validation of a Fully Integrated NGS Platform in the Real-World Practice of Italian Referral Institutions 153
EGFR mutations detected on cytology samples by a centralized laboratory reliably predict response to gefitinib in non-small cell lung carcinoma patients. 153
Performance evaluation of a fully closed real-time PCR platform for the detection of KRAS p.G12C mutations in liquid biopsy of patients with non-small cell lung cancer 150
Cytopathology practice during the COVID-19 postlockdown: An Italian experience 150
Rapid On-site Molecular Evaluation in thyroid cytopathology: A same-day cytological and molecular diagnosis 148
Evaluation of the Molecular Landscape in PD-L1 Positive Metastatic NSCLC: Data from Campania, Italy 146
A Roadmap for a Comprehensive Diagnostic Approach to Fine Needle Cytology of Lymph Node Metastases 146
Non-Small Cell Lung Cancer Testing on Reference Specimens: An Italian Multicenter Experience 146
PD-L1 expression in cell-blocks of non-small cell lung cancer: The impact of prolonged fixation 145
Impact of Pre-Analytical Factors on MSI Test Accuracy in Mucinous Colorectal Adenocarcinoma: A Multi-Assay Concordance Study 142
Ciliated foregut cyst of the pancreas: A benign lesion with elevated CEA levels 141
RNA-based next generation sequencing in non-small-cell lung cancer in a routine setting: an experience from an Italian referral center 139
RNA-Based Assay for Next-Generation Sequencing of Clinically Relevant Gene Fusions in Non-Small Cell Lung Cancer 137
Multiplex digital colour-coded barcode technology on RNA extracted from routine cytological samples of patients with non-small cell lung cancer: pilot study 135
PD-L1 expression on routine samples of non-small cell lung cancer: Results and critical issues from a 1-year experience of a centralised laboratory 135
Development of a gene panel for next-generation sequencing of clinically relevant mutations in cell-free DNA from cancer patients 133
Liquid biopsy for BRAF mutations testing in non-small cell lung cancer: A retrospective study 132
EGFR mutation detection on lung cancer cytological specimens by the novel fully automated PCR-based Idylla EGFR Mutation Assay 129
Immunohistochemical Nuclear Expression of β-Catenin as a Surrogate of CTNNB1 Exon 3 Mutation in Endometrial Cancer 129
Performance of EGFR mutant-specific antibodies in different cytological preparations: a validation study 128
Cytology meets next generation sequencing and liquid biopsy: A case of lung adenocarcinoma presenting as metastasis to the phalanx 128
Methods for actionable gene fusion detection in lung cancer: now and in the future 127
Moving towards a local testing solution for undetermined thyroid fine-needle aspirates: validation of a novel custom DNA-based NGS panel 127
Evaluation of a fully closed real time PCR platform for the detection of SARS-CoV-2 in nasopharyngeal swabs: a pilot study 125
SANGER SEQUENCING IN ROUTINE KRAS TESTING: AREVIEW OF 1720 CASES FROM A PATHOLOGIST’SPERSPECTIVE 124
Predictive molecular pathology in the time of COVID-19 123
Harmonization of Next-Generation Sequencing Procedure in Italian Laboratories: A Multi-Institutional Evaluation of the SiRe® Panel 123
EGFR mutation detection by microfluidic technology: a validation study. 120
KRAS mutations testing in non-small cell lung cancer: The role of Liquid biopsy in the basal setting 120
There is still a role for cytology in the 'liquid biopsy' era. A lesson from a TKI-treated patient showing adenocarcinoma to squamous cell carcinoma transition during disease progression 119
KRAS detection on archival cytological smears by the novel fully automated polymerase chain reaction-based Idylla mutation test 118
How Molecular and Ancillary Tests Can Help in Challenging Cytopathology Cases: Insights from the International Molecular Cytopathology Meeting 117
Is the Idylla EGFR Mutation Assay feasible on archival stained cytological smears? A pilot study 117
Evaluation of Micro Satellite Instability and Mismatch Repair Status in Different Solid Tumors: A Multicenter Analysis in a Real World Setting 117
A narrative review of predictive immuno-histo/cyto chemistry in lung cancer: focus on gene fusions and PD-L1 expression 115
PD-L1 and beyond: Immuno-oncology in cytopathology 115
Fully automated PCR detection of KRAS mutations on pancreatic endoscopic ultrasound fine-needle aspirates 114
KRAS testing in metastatic colorectal carcinoma: challenges, controversies, breakthroughs, and beyond 113
EGFR mutant allelic-specific imbalance assessment in routine samples of non-small cell lung cancer 113
Tumor mutational burden on cytological samples: A pilot study 113
KRAS mutation detection by high resolution melting analysis significantly predicts clinical benefit of cetuximab in metastatic colorectal cancer 112
Idylla assay and next generation sequencing: an integrated EGFR mutational testing algorithm 112
A challenging case of enteric-type lung adenocarcinoma metastatic to the thyroid harboring RET-fusion diagnosed on fine-needle aspiration 111
EGFR mutation detection on routine cytological smears of non-small cell lung cancer by digital PCR: A validation study 111
EGFR exon 19 deletion switch and development of p.L792Q mutation as a new resistance mechanism to osimertinib: A case report and literature review 110
Dealing with NSCLC EGFR mutation testing and treatment: A comprehensive review with an Italian real-world perspective 109
EGFR analysis: Current evidence and future directions 108
Unusual Clinical Experience in BRAF Exon 15 p.K601E-Mutated Lung Cancer: A Case Report and Brief Review of the Literature 103
Diagnostic accuracy of p53 immunohistochemistry as surrogate of TP53 sequencing in endometrial cancer 102
Concomitant Rare KRAS and BRAF Mutations in Lung Adenocarcinoma: A Case Report 100
MMR profile and microsatellite instability status in colorectal mucinous adenocarcinoma with synchronous metastasis: a new clue for the clinical practice 99
Bird's eye view of modern cytopathology: Report from the seventh international Molecular Cytopathology Meeting in Naples, Italy, 2018 96
Outsourcing cytological samples to a referral laboratory for EGFR testing in non-small cell lung cancer: does theory meet practice? 94
Evaluation of KRAS, NRAS and BRAF mutational status and microsatellite instability in early colorectal carcinomas invading the submucosa (pT1): Towards an in-house molecular prognostication for pathologists? 94
Molecular testing in salivary gland cytopathology: A practical overview in conjunction with the Milan system 91
RNA-Based Next-Generation Sequencing in Non-Small Cell Lung Cancer patients: data from Campania, Italy 90
SIMULTANEOUS VULVAR AND PARENCHIMAL BRAIN LANGERHANS CELL HISTIOCYTOSIS: ASSOCIATION OR COINCIDENCE? 90
Molecular Testing of Thyroid Fine-Needle Aspiration: Local Issues and Solutions. An Interventional Cytopathologist Perspective 87
Cytopathology Practice in the COVID-19 Era: Focus on Sample Workload 85
Critical aspects of MSI testing in endometrial cancer: a comparison study 84
Epidermal Growth Factor Receptor Test Performed on Liquid-Based Cytology Lung Samples: Experience of an Academic Referral Center. 82
Clear Cell Neoplasm in Salivary Gland FNA? Maybe It’s From Kidney! 72
Challenges and opportunities of next-generation sequencing: a cytopathologist's perspective 70
Evaluation of a New Ethanol-Based Preservative Medium for Liquid-Based Cervical Cytology: A Performance Pilot Study for Molecular Applications 67
Nanoscale Prognosis of Colorectal Cancer Metastasis from AFM Image Processing of Histological Sections 67
The development of a narrow target gene panel makes next generation sequencing effective for circulating free DNA analysis 66
Molecular predictive testing in precision oncology: The Italian experience 59
The relevance of the reference range for EGFR testing in non-small cell lung cancer patients 56
Understanding EGFR heterogeneity in lung cancer 48
Liquid biopsy for lung cancer: A cross section on the diagnostic routine experience of a referral Italian institution 33
ERBB2 Mutation Testing in NSCLC: A Pan-European Real-World Evaluation of the Oncomine Precision Assay 19
Analytical reliability of cell-free DNA from fine-needle aspiration rinses for BRAF and NRAS testing in metastatic melanoma 9
Totale 8.239
Salva come PNG Salva come JPEG
Categoria #
all - tutte 24.955
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.955
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202153 0 0 0 0 0 0 0 0 0 26 9 18
2021/2022359 9 4 5 9 5 3 4 32 30 38 91 129
2022/2023575 58 37 25 51 71 69 0 70 106 41 31 16
2023/2024332 26 69 31 17 12 9 16 56 11 3 55 27
2024/20252.282 84 139 11 11 67 97 212 140 124 304 897 196
2025/20264.246 444 331 454 369 738 183 650 239 561 277 0 0
Totale 8.239